These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2714884)

  • 1. A case-control study of cancer of endometrium in Athens.
    Koumantaki Y; Tzonou A; Koumantakis E; Kaklamani E; Aravantinos D; Trichopoulos D
    Int J Cancer; 1989 May; 43(5):795-9. PubMed ID: 2714884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of ovarian cancer in Greece: a case-control study.
    Tzonou A; Day NE; Trichopoulos D; Walker A; Saliaraki M; Papapostolou M; Polychronopoulou A
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1045-52. PubMed ID: 6540687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of cancer of the endometrium.
    Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Mostow ED; Schwartz PE; O'Connor T; White C
    Am J Epidemiol; 1982 Aug; 116(2):333-42. PubMed ID: 7114042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables.
    Kalandidi A; Tzonou A; Lipworth L; Gamatsi I; Filippa D; Trichopoulos D
    Oncology; 1996; 53(5):354-9. PubMed ID: 8784467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of endometrial cancer in young women.
    Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
    Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for adenomatous endometrial hyperplasia: a case-control study.
    Kreiger N; Marrett LD; Clarke EA; Hilditch S; Woolever CA
    Am J Epidemiol; 1986 Feb; 123(2):291-301. PubMed ID: 3946378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus.
    Schwartz SM; Weiss NS; Daling JR; Gammon MD; Liff JM; Watt J; Lynch CF; Newcomb PA; Armstrong BK; Thompson WD
    Cancer; 1996 Feb; 77(4):717-24. PubMed ID: 8616764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS; Sayvetz TA
    N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives, menopausal estrogens, and the risk of breast cancer: a case-control study in Greece.
    Lipworth L; Katsouyanni K; Stuver S; Samoli E; Hankinson SE; Trichopoulos D
    Int J Cancer; 1995 Sep; 62(5):548-51. PubMed ID: 7665225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
    Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
    Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
    McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
    Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for endometrial cancer at different ages.
    La Vecchia C; Franceschi S; Decarli A; Gallus G; Tognoni G
    J Natl Cancer Inst; 1984 Sep; 73(3):667-71. PubMed ID: 6590913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk.
    Key TJ; Pike MC
    Br J Cancer; 1988 Feb; 57(2):205-12. PubMed ID: 3358913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine estrogens and breast cancer risk factors among post-menopausal women.
    Trichopoulos D; Brown J; MacMahon B
    Int J Cancer; 1987 Dec; 40(6):721-5. PubMed ID: 3692620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and endometrial cancer: do other risk factors modify the association?
    Stanford JL; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Hoover RN
    Int J Cancer; 1993 May; 54(2):243-8. PubMed ID: 8486426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estrogen therapy and carcinoma of the endometrium (author's transl)].
    Völker W; Kannengiesser U; Majewski A; Vasterling HW
    Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):735-43. PubMed ID: 210085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormones in the etiology and prevention of breast and endometrial cancer.
    Gambrell RD
    South Med J; 1984 Dec; 77(12):1509-15. PubMed ID: 6505760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women.
    Osterlind A; Tucker MA; Stone BJ; Jensen OM
    Int J Cancer; 1988 Dec; 42(6):821-4. PubMed ID: 3192324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.